The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

 
Web www.patentalert.com

< METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE

> LEUCINE-BASED MOTIF AND CLOSTRIDIAL NEUROTOXINS

~ 00458